Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Jasper Therapeutics, Maintains $6.85 Price Target By Benzinga Newsdesk February 27, 8:08 AM EF Hutton analyst Michael King reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Buy and maintains $6.85 price target. JSPR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Cowen & Co. Reiterates Market Perform on Restaurant Brands Intl, Maintains $72 Price Target By Benzinga Newsdesk February 27, 8:00 AM Cowen & Co. analyst Andrew Charles reiterates Restaurant Brands Intl (NYSE:QSR) with a Market Perform and maintains $72 price target. QSR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Okta, Maintains $90 Price Target By Benzinga Newsdesk February 27, 7:58 AM Needham analyst Alex Henderson reiterates Okta (NASDAQ:OKTA) with a Buy and maintains $90 price target. OKTA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on ACM Research, Maintains $15 Price Target By Benzinga Newsdesk February 27, 7:56 AM Needham analyst Quinn Bolton reiterates ACM Research (NASDAQ:ACMR) with a Buy and maintains $15 price target. ACMR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Strong Buy on Zscaler, Maintains $210 Price Target By Benzinga Newsdesk February 27, 7:37 AM Needham analyst Alex Henderson reiterates Zscaler (NASDAQ:ZS) with a Strong Buy and maintains $210 price target. ZS
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Karuna Therapeutics, Maintains $320 Price Target By Benzinga Newsdesk February 27, 7:12 AM HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Karuna Therapeutics (NASDAQ:KRTX) with a Buy and maintains $320 price target. KRTX
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $3.5 Price Target By Benzinga Newsdesk February 27, 7:07 AM HC Wainwright & Co. analyst Sean Lee reiterates Plus Therapeutics (NASDAQ:PSTV) with a Buy and maintains $3.5 price target. PSTV
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Market Perform on Stitch Fix, Maintains $5 Price Target By Benzinga Newsdesk February 27, 6:09 AM Telsey Advisory Group analyst Dana Telsey reiterates Stitch Fix (NASDAQ:SFIX) with a Market Perform and maintains $5 price target. SFIX
Read More 1 minute read Analyst Ratings News Price Target Reiteration Piper Sandler Reiterates Overweight on Freshworks, Maintains $20 Price Target By Benzinga Newsdesk February 27, 5:33 AM Piper Sandler analyst Brent Bracelin reiterates Freshworks (NASDAQ:FRSH) with a Overweight and maintains $20 price target. FRSH
Read More 2 minute read Analyst Color Analyst Ratings Price Target Reiteration Top Stories Trading Ideas Boeing Analysts Recommend Caution Following Latest 787 Production Problems By Wayne Duggan February 24, 4:19 PM Boeing Co (NYSE: BA) shares dropped 4.8% on Friday after the company announced it had once again run into production problems with its 787 Dreamliner. BA